Canon Leans on A.I. for Innovation in the Camera Biz
Canon ranked among the top holders of U.S. patents in 2017, beating out Intel, Google, and Amazon. The camera company placed a focus on intellectual property, using imaging technology to drive innovation across industries including business solutions, manufacturing, and medical technology.
Robert Pignataro, Director of New Business for Imaging Technologies & Communications Group at Canon, joined us to share how the company is innovating in the camera business. There are some Canon patents consumers interact with on a daily basis without even realizing. He said every time we turn on the TV, we see the result of their cinema line. The company received a technical Emmy last year for its Cinema U.S. lenses.
A.I. is a big part of Canon's industrial focus. Pignataro said Canon has become more of a software company to help encompass the strength of its hardware. It’s not just cameras. He said innovation in its printing segment has been key as well.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Scott Trench, host of the BiggerPockets Money Podcast, explores how recent rate cuts, high borrowing costs, and mortgage rates are reshaping U.S. real estate.
A look into how disruption, AI, and global economic trends are transforming the modern supply chain with Jeremy Jansen, Head of Supply Chain at Wells Fargo.
